NO951165L - Purinderivater og suppresjonspreparater for inflammasjons-sykdommer - Google Patents

Purinderivater og suppresjonspreparater for inflammasjons-sykdommer

Info

Publication number
NO951165L
NO951165L NO951165A NO951165A NO951165L NO 951165 L NO951165 L NO 951165L NO 951165 A NO951165 A NO 951165A NO 951165 A NO951165 A NO 951165A NO 951165 L NO951165 L NO 951165L
Authority
NO
Norway
Prior art keywords
suppressants
inflammatory diseases
purine derivatives
purine
derivatives
Prior art date
Application number
NO951165A
Other languages
English (en)
Other versions
NO951165D0 (no
NO307608B1 (no
Inventor
Yoshiaki Isobe
Nobuyoshi Chiba
Yuso Goto
Hideharu Sato
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7465195A external-priority patent/JPH07316157A/ja
Priority claimed from JP7739495A external-priority patent/JP3491711B2/ja
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO951165D0 publication Critical patent/NO951165D0/no
Publication of NO951165L publication Critical patent/NO951165L/no
Publication of NO307608B1 publication Critical patent/NO307608B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO951165A 1994-03-28 1995-03-27 Purinderivater og suppresjonspreparater for inflammasjonssykdommer NO307608B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8100094 1994-03-28
JP7465195A JPH07316157A (ja) 1994-03-28 1995-03-07 ヒポキサンチン誘導体及び炎症性疾患の抑制剤
JP7739495A JP3491711B2 (ja) 1994-03-28 1995-03-08 プリン誘導体及び炎症性疾患の抑制剤

Publications (3)

Publication Number Publication Date
NO951165D0 NO951165D0 (no) 1995-03-27
NO951165L true NO951165L (no) 1995-09-29
NO307608B1 NO307608B1 (no) 2000-05-02

Family

ID=27301573

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951165A NO307608B1 (no) 1994-03-28 1995-03-27 Purinderivater og suppresjonspreparater for inflammasjonssykdommer

Country Status (4)

Country Link
US (1) US5602140A (no)
EP (1) EP0675124A3 (no)
FI (1) FI951367A7 (no)
NO (1) NO307608B1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US6294541B1 (en) 1996-06-06 2001-09-25 Euro-Celtique S.A. Purine derivatives having phosphodiesterase IV inhibition activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
CA2295811A1 (en) * 1997-07-15 1999-01-20 Japan Energy Corporation Novel purine derivatives and their use as medicines
DE19882892T1 (de) 1997-12-12 2001-02-22 Euro Celtique Sa Herstellung von 3-substituierten Adeninen und Imidazopyridinen
US6319928B1 (en) 1998-11-30 2001-11-20 Euro-Celtique, S.A. Purine derivatives having phosphodiesterase IV inhibition activity
AR029347A1 (es) 1999-04-02 2003-06-25 Euro Celtique Sa Compuesto de adenina, compuesto de isognanina y 2,6-ditioxantina como precursor del mismo, uso de dichos compuestos para preparar una composicion farmaceutica y dicha composicion farmaceutica
GB9924020D0 (en) 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
JP2003513756A (ja) * 1999-11-12 2003-04-15 アンジオテック ファーマシューティカルズ，インコーポレイテッド 放射性治療と細胞周期インヒビターとの組合せの組成物
EP1939203B1 (en) * 2000-04-25 2014-11-19 ICOS Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
ES2788383T3 (es) * 2000-04-25 2020-10-21 Icos Corp Inhibidores de delta fosfatidilo-inositol 3-quinasa humana
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
SI2612862T1 (sl) 2004-05-13 2017-04-26 Icos Corporation Kinazolini kot inhibitorji humane fosfatidilinozitol 3-kinaze delta
US20060046877A1 (en) * 2004-08-31 2006-03-02 Gajda William G Jr Foam projectile with suction cup tip
WO2008092860A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
WO2008092861A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
WO2008092862A1 (en) * 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
CN102271683B (zh) 2008-11-13 2014-07-09 吉里德卡利斯托加公司 恶性血液病的治疗
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CA2756347A1 (en) 2009-03-24 2010-09-30 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
CN102458410A (zh) 2009-04-20 2012-05-16 吉联亚·卡利斯托加有限责任公司 治疗实体瘤的方法
EA201270184A1 (ru) 2009-07-21 2012-08-30 ГИЛИЭД КАЛИСТОГА ЭлЭлСи Лечение расстройств печени ингибиторами pi3k
WO2011106168A1 (en) * 2010-02-24 2011-09-01 Dcam Pharma Inc Purine compounds for treating autoimmune and demyelinating diseases
WO2012167053A1 (en) * 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
SI2834241T1 (sl) 2012-03-05 2021-06-30 Gilead Calistoga Llc Polimorfne oblike (S)-2-(1-(9H-purin-6-ilamino)propil)-5-fluoro-3-fenilkinazolin-4(3H)-ONA
WO2015095601A1 (en) 2013-12-20 2015-06-25 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
EP3154960A1 (en) 2014-06-13 2017-04-19 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153293B (it) * 1982-10-22 1987-01-14 Francia Famaceutici S R L Derivati del 4-idrossi-2-metil-2h-1, 2-benzotiazina-3-carbossamide 1, 1-biossido e procedimento per la loro preparazione
US5098906A (en) * 1983-10-31 1992-03-24 Warner-Lambert Company Purine derivatives
JPS60260579A (ja) * 1984-01-13 1985-12-23 Yoshitomi Pharmaceut Ind Ltd プリン誘導体
US4772606A (en) * 1985-08-22 1988-09-20 Warner-Lambert Company Purine derivatives
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
DE3869202D1 (de) * 1987-03-17 1992-04-23 Merrell Dow Pharma Alkylidendithiobis (substituierte) phenolen zur hemmung der freisetzung von interleukin-1 und zur linderung von interleukin-1 vermittelten krankheiten.
US4975467A (en) * 1987-03-17 1990-12-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
NZ231534A (en) * 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
US5270465A (en) * 1989-03-30 1993-12-14 Lipha, Lyonnaise Industrille Pharmaceutique 4(3H)-pteridinone compounds
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
NO951165D0 (no) 1995-03-27
FI951367A0 (fi) 1995-03-23
NO307608B1 (no) 2000-05-02
FI951367A7 (fi) 1995-09-29
US5602140A (en) 1997-02-11
EP0675124A2 (en) 1995-10-04
EP0675124A3 (en) 1996-08-21

Similar Documents

Publication Publication Date Title
NO951165D0 (no) Purinderivater og suppresjonspreparater for inflammasjons-sykdommer
NO990700L (no) Propionsyrederivater og anvendelsen herav
IS4481A (is) Díhýdrópyramídín og notkun þeirra
NO982265D0 (no) Diagnostikk for og mediatoter for inflammatoriske forstyrrelser
DK0821920T3 (da) Stent
NO2008002I1 (no) Protiokonazol og salter derav
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
PT769965E (pt) Formulacoes aquosas de risperidona
NO975977D0 (no) Substituerte purinderivater, fremgangsmåter for fremstilling og anvendelse derav
NO963709D0 (no) Forsterkerkrets
DK183488D0 (da) Furanderivater og anvendelse deraf
NO971505D0 (no) Trofinin og trofininhjelperproteiner
FI971193A7 (fi) Hoidossa käyttökelpoisia kinoksaliinijohdannaisia
EP0797450A4 (en) In vitro t-lymphopoiesis system
FI970195L (fi) Trifluormetyylikinoliinikarboksyylihappojohdannainen
ATA194094A (de) Artikulator
NO20000184D0 (no) Nye purinderivater og medisinsk anvendelse derav
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
FI964468A7 (fi) Adenosiinijohdannaisia
SE9403189L (sv) Inställningsorgan
KR960000302U (ko) 촬영 보조의자
SE9402962D0 (sv) Utslagsplattform
NO914895L (no) Naftyloksybenzo- og naftyloksynaftosyrederivater og deresfremstilling
BR7200603U (pt) Disposicao para manequim para protese total
KR950029612U (ko) 볼링핀

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees